市場調查報告書
商品編碼
1614806
亞太地區目標定序市場:按應用、按產品類型、靶向序列捕獲方法、按目標捕獲類型、按最終用戶、按國家/地區 - 分析和預測 (2024-2033)Asia-Pacific Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033 |
2023年亞太地區標靶定序市場規模為5.742億美元。
預計2024年至2033年該市場將以14.35%的複合年成長率成長,2033年達到21.755億美元。亞太地區標靶定序市場競爭激烈,現有企業和新興企業在爭奪市場佔有率。未來幾年,市場預計將持續發展和轉型,機會與挑戰並存,因此密切關注市場的動態和快速變化至關重要。
主要市場統計數據 | |
---|---|
預測期 | 2024-2033 |
2024年評估 | 6.509 億美元 |
2033 年預測 | 21.755 億美元 |
複合年成長率 | 14.35% |
對經濟實惠且高度準確的測序技術的需求不斷成長、精準醫學的使用不斷增加以及基因組學的進步都促進了亞太地區靶向定序市場的顯著成長。特定基因或感興趣區域的標靶定序正變得越來越流行,因為它是全基因組定序的經濟有效的替代方案。中國、日本、韓國和印度等國家由於強力的政府資助、不斷擴大的研究舉措和不斷擴大的生物技術領域而主導了市場。
癌症和遺傳性疾病等慢性疾病的增加增加了標靶定序在臨床診斷和個人化治療方法中的應用。由於次世代定序(NGS)平台的技術開拓以及學術機構和公司之間的夥伴關係不斷增強,該市場正在不斷擴大。此外,亞太地區人口眾多,加上基於基因組學的醫療保健意識不斷增強,為市場相關人員提供了巨大的商機。
此外,靶向定序因其成本效益而對臨床和研究應用特別有吸引力,可以更深入地了解遺傳變異,同時簡化資料分析。由於基因組研究投資的增加,亞太地區標靶定序市場預計將顯著成長,有助於該地區精準醫學和基因組研究的進步。
該報告研究了亞太地區目標定序市場,並按應用、產品類型、靶向序列捕獲方法、目標捕獲類型、最終用戶、國家和市場趨勢提供了市場概況。
Introduction to Asia-Pacific Targeted Sequencing Market
The Asia-Pacific targeted sequencing market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033. The APAC targeted sequencing market is fiercely competitive, with both established players and emerging companies vying for market share. It will be crucial to keep an eye on the market's dynamic and quickly changing landscape in the upcoming years as a result of its anticipated growth and transformation, which present both opportunities and challenges.
Market Introduction
KEY MARKET STATISTICS | |
---|---|
Forecast Period | 2024 - 2033 |
2024 Evaluation | $650.9 Million |
2033 Forecast | $2,175.5 Million |
CAGR | 14.35% |
The growing demand for affordable, high-accuracy sequencing technologies, the growing use of precision medicine, and genomics advancements are all contributing to the notable growth of the APAC targeted sequencing market. Because it provides a cost-effective and efficient substitute for whole genome sequencing, targeted sequencing-which concentrates on particular genes or regions of interest-is becoming more and more popular. Thanks to strong government funding, growing research initiatives, and the expanding biotechnology sector, nations like China, Japan, South Korea, and India are dominating the market.
The use of targeted sequencing for clinical diagnostics and individualized treatment regimens has increased due to the rise in chronic diseases, such as cancer and genetic disorders. The market is growing as a result of technological developments in next-generation sequencing (NGS) platforms and growing partnerships between academic institutions and business entities. Additionally, the APAC region's large population, coupled with growing awareness about genomics-based healthcare, creates significant opportunities for market players.
Furthermore, targeted sequencing is particularly appealing for clinical and research applications due to its cost-effectiveness, which allows for deeper understanding of genetic variations while simplifying data analysis. The APAC targeted sequencing market is expected to grow significantly as genomics research investments rise, contributing to the advancement of precision medicine and genomic research in the region.
Market Segmentation
Segmentation 1: by Application
Segmentation 2: by End User
Segmentation 3: by Product Type
Segmentation 4: by Target Enrichment Method
Segmentation 5: by Target Capture
Segmentation 6: by Country
How can this report add value to an organization?
Workflow/Innovation Strategy: The Asia-Pacific targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Asia-Pacific targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some of the prominent companies in this market are:
Scope and Definition